I wasn't surprised that none of the eight Boston-based companies on Luke's list didn't have SBIR/STTR funding. Boston is doing--or can do--deals, right? But then I thought more about the heat map. Certainly Massachusetts has it's fair share of academic/research institutions that can crank out life science technology to support SBIR/STTR proposals. Is there a correlation between the number of SBIR/STTR awards in Massachusetts and The Entrepreneurial Diaspora Enabled By Biotech M&A, particularly in the Boston MSA?
In other words, is it more apt to happen that a PI will hook up with a recycled talented team?